Degradation of polyurethanes in vitro and in vitro: comparison of different models by Frautschi, Jack R. et al.
Colloids and Surfhces B Brointer$rces. 1 (1993) 305-313 
0927-7765/93/$06.00 #cl 1993 - Elsevier Sctence Publishers B.V. All rights reserved. 
30s 
Degradation of polyurethanes in vitro and in vivo: 
comparison of different models” 
Jack R. Frautschiaq*, Joseph A. Chinn”, Richard E. Phillips, Jr.“, Q.H. Zhaob, 
James M. Andersonb, Ravi Joshi”, Robert J. Levy” 
“CnrboMedics. 1300 B East Anderson Lane. Austin, TX 78752-1793, USA 
bDepartments of Macromolecular Science and Pathology, Case Western Reserve University, Clevelund. 
OH 44106, USA 
‘Department oj’pediatrics, University of Michigan Medical Center, Ann Arbor, MI 48109-0576, USA 
(Received 8 February 1993; accepted 4 May 1993) 
Abstract 
This study compares and contrasts mechanisms of polyetherurethane (PEU) degradation m vitro and in vivo. Models 
comprising incubation with hydrogen peroxide in vitro (H202). m vtvo subcutaneous rat implant (SUBQ). and 
subcutaneous rat cage implant (CAGE) are described and compared with in vivo degradation of the pacemaker lead 
device retrieved after human implant (PACE). Experimental results support the hypothesis that stress accelerates PEU 
degradation. Scanning electron microscopy (SEMI, gel permeation chromatography (GPC), and Fourier transform IR 
spectroscopy/attenuated total reflectance (FT-IR/ATR) evaluation of tested PEU samples suggests, for all models. 
decreased soft segment and increased ester functtonality at the polymer surface These observations are consistent with 
a single, metal ton catalyzed. polyester intermediate, oxidative degradation mechanism common to all models, and 
with device performance m VIVO. Model comparison suggests that m vitro H,Oz and in vivo SUBQ and CAGE models 
accurately mimic m vtvo degradation of the pacemaker lead device (PACE). 
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Introduction 
Polyetherurethanes (PEUs) are commonly used 
in biomedical applications due to their good 
mechanical properties [l] and relative biocompati- 
bility [2]. Devices fabricated from PEU include 
artificial heart diaphragms, ventricular assist 
devices, pacemaker leads, and vascular grafts [3]. 
However, the in vivo stability of PEU has been 
questioned [4,5]. Premature failure of PEU cardiac 
pacing lead insulation has been reported [6-83. 
Further, degradation of PEU was related to the 
quantity of soft segment in the polymer, i.e. stability 
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increased with decreased ether content [9]. Metal 
ion catalyzed degradation has been proposed 
[lO,ll]. 
While PEU degradation in vitro upon incuba- 
tion with enzyme [12-141 and metal ion solution 
[I 51 have been reported, more recent studies report 
oxidative degradation of PEU upon incubation 
with hydrogen peroxide [16,17]. The relevance of 
both oxidative and enzymatic PEU degradation in 
vivo remains uncertain. However, it is likely that 
dynamic interactions between cells and the polymer 
surface are relevant to PEU degradation. Initially, 
polymorphonuclear leukocytes (PMNs) are 
thought to undergo cellular activation, then 
become displaced by macrophages. These cells then 
coalesce to form foreign body giant cells (FBGCs) 
[ 181, which are purported to produce oxidizing 
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agents such as hydrogen peroxide [ 191. Preferential 
PEU degradation at the site of FBGC adherence 
has also been reported [20]. 
In this study, PEU degradation observed in the 
in vitro HzO, model [IO] is compared with that 
observed in the in vivo SUBQ [21] and CAGE 
[22] models. and with that observed in PEU 
pacemaker leads retrieved after human implant. 
Based upon chemical evaluation of samples tested 
in each model, we propose that oxidative degrada- 
tion occurs by a single, common, metal ion cata- 
lyzed mechanism through a polyester intermediate. 
Experimental 
In vitro incubation of pacemaker leads with 
h)ldrogen peroxide ( H202) 
The in vitro degradation model has been 
described previously [lo]. Briefly, pacing leads 
comprising a nickel-cobalt coil coated with brazed 
silver and insulated with Pellethane (PEU, Dow 
Chemical, Midland, MI) were electronically paced 
in 3% H,Oz for 180 days at 37’C. The solution 
was changed three times per week. Control samples 
were incubated with Ringer’s lactate solution 
(2.58 g I- ’ NaCH,CH(OH)CO,H, 6.00 g 1~ ’ NaCl, 
0.30 g l- ’ KCl, 0.20 g 1~ ’ CaC12.2H,0, pH 6.8). 
Samples were examined by scanning electron 
microscopy (SEM) (JSM-5400, Joel, Tokyo. Japan) 
for indications of gross degradation. SEM samples 
were sputter coated with gold-palladium to 100 A 
and examined at an accelerating voltage of 15 keV. 
Fourier transform IR spectroscopy/attenuated 
total reflectance (FT-IR/ATR)(FTS-40, BioRad, 
Boston, MA) was used to detect chemical changes 
that occurred during peroxide incubation. The 
ATR attachment utilized a KRS-5 crystal at an 
angle of 45”, which corresponds to a surface depth 
of approximately I urn. Molecular weight distribu- 
tions of test and control samples were measured 
by gel permeation chromatography (GPC)(GPC 
II, Waters, Milford, MA) and compared. N,N- 
dimethylacetamide (DMAC) was used as the car- 
rier solvent and polystyrene as the molecular 
weight standard. 
In oiuo subcutaneous rat implant model of polymer 
degradation (SUBQl 
The SUBQ model, which has typically been used 
to evaluate calcification of pericardial tissue 
samples, has been described previously [Zl]. 
Briefly, dry Mitrathane (polyetherurethane urea 
(PEUU). Polymedica, Denver, CO) was dissolved 
at 10%’ (w/v) in DMAC and poured onto a Teflon 
plate. After solvent was evaporated under vacuum, 
the polymer sheet was peeled from the plate. From 
the sheet were cut substrate samples (1.0 cm2, 
0.023 cm thickness), which were then dipped in 
10%’ (w/v) Biomer (PEUU, Ethicon, Somerville, 
NJ) in DMAC, and dried under vacuum. The 
dipping procedure was repeated until sample thick- 
ness was 0.038 cm. Fifteen Biomer-coated 
Mitrathane samples were annealed at 125°C for 
1 h to remove residual stress, then implanted sub- 
cutaneously in SpragueeDawley rats as follows. 
(Biomer-coated Mitrathane samples rather than 
Biomer samples were used for reasons unrelated 
to PEU degradation.) 
Rats weighing 50-60 g (Charles River Labs) were 
anesthetized with an intraperitoneal injection of 
0.00857 mg g- ’ xylazine and 0.057 mg g- ’ keta- 
mine. A small incision was made on the abdominal 
midline with scissors. The scissors were inserted 
into the incision and used to blunt dissect a 
subcutaneous pouch. A separate pouch was made 
for each implant. Four samples were implanted 
per animal, and samples were placed 2 cm apart. 
Each sample was inserted with forceps and the 
opening closed with a stainless steel wound clip. 
Each animal was again weighed following surgery 
and an identification tag placed on its ear. 
Samples were retrieved after 60 days, rinsed in 
distilled, deionized water, and photographed. 
Samples were then examined under SEM, incu- 
bated with 0.6% buffered pepsin solution and exam- 
ined by FT-IR/ATR. or incubated first with pepsin, 
then with solvent in an attempt to solubilize from 
J.R. Frautschi et aI./Colloids Surfaces B. Biointerfaces 1 (19931 30.5 313 307 
the bulk sample the topmost surface layers, from 
which molecular weight distribution was measured 
by GPC. 
In vivo subcutaneous rat cage implant model 
(CAGE) 
The CAGE model has also been described pre- 
viously [ 111. Briefly, either dry Biomer, or a propri- 
etary dry Biomer-like polymer, “B2”, was dissolved 
at 10% (w/v) in DMAC then cast against Teflon 
rods of 4 mm. After solvent was evaporated under 
vacuum, each cast tube was extracted for 24 h with 
sterile, deionized water and dried to constant 
weight. Samples were cut to 2 mm specimens, each 
of which was strained to 400%, secured around a 
polysulfone mandrel, then sutured with Green 
“Silky” II PolyDEK 108-Y 4-O (Deknatel, Fall 
River, MA; catalog number X-5262). Test speci- 
mens were trimmed as necessary, sterilized with 
ethylene oxide, and placed into stainless steel mesh 
cages. Fifteen samples of each test material were 
then implanted subcutaneously in Sprague- 
Dawley rats (one sample per cage, one cage per 
animal). 
Samples were retrieved after 5, 10, and 15 weeks 
and rinsed in distilled, deionized water. Samples 
were then either examined for rupture and cracking 
under SEM, or examined for chemical changes by 
FT-IR/ATR. 
Human pacemaker lead device implant (PACE) 
Pacer leads comprising an MP-35N nickel-co- 
balttchromium coil insulated with Pellethane were 
retrieved after 3 years human implant and returned 
for analysis. Proteinaceous deposits were removed 
by 24 h incubation with 0.6% buffered pepsin solu- 
tion. Pellethane insulation was then analyzed for 
chemical changes by FT-IR/ATR. 
Results 
SEM examination of degraded PEU samples 
SEM micrographs of PEU samples before and 
after testing reveal significant degradation in some 
but not all models. Comparison of the Biomer 
sample prior to implant (CONTROL; Fig. l(a)) 
with the Biomer sample retrieved after 60 days 
subcutaneous, unstressed, uncaged, rat implant 
(SUBQ; Fig. l(b)) reveals no visual degradation. 
However, surface cracks and rupture were observed 
on Biomer samples retrieved after 10 weeks subcu- 
taneous, stressed, caged, rat implant (CAGE; 
Fig. l(c)). SEM micrographs of Biomer samples 
retrieved after 5 and 15 weeks, and of B2 samples 
retrieved after 5, 10, and 15 weeks were similar 
(data not shown). Comparison of the inner lumen 
of the Pellethane pacer lead prior to pacing in 
hydrogen peroxide (CONTROL; Fig. 2(a)) with the 
inner lumen of the lead paced 180 days in hydrogen 
peroxide reveals large surface cracks in the polymer 
(H,Oz; Fig. 2(b)). Comparison of the external sur- 
face of the Pellethane lead prior to implant 
(CONTROL; Fig. 3(a)) with the exterior surface of 
the lead retrieved after 3 years human implant 
(PACE; Fig. 3(b)) reveals similar cracking. 
Cracks in the Pellethane leads were observed 
only at sites of externally applied stress, both in 
vitro (H202) and in vivo (PACE). Stress in H,O, 
was applied where the lead emerged from the 
apparatus, while stress in PACE was applied by 
coiling a section of the lead that was implanted 
subcutaneously. 
FT-IRIATR examination of degraded PEV samples 
FT-IR/ATR spectra of Biomer degraded in vivo 
appear in Figs. 4(a) and 4(b) (SUBQ and CAGE, 
respectively). Spectra of Pellethane degraded in 
vitro (H,O,) and in vivo (PACE) appear in Figs. 
5(a) and 5(b), respectively. Main peak assignments 
for both Pellethane and Biomer have been reported 
previously [23]. 
Measurement of polymer molecular weight 
distribution by GPC 
GPC measurement of the molecular weight dis- 
tribution of Pellethane (H202) samples reveals 
significant reduction in number average molecular 




Fig. 2. (a) SEM micrograph of Pellethane pacer lead (inner 
lumenal surface) prior to incubation with hydrogen peroxide: 
magnification, 500 x (CONTROL). (b) SEM micrograph of 
Pellethane pacemaker lead (inter lumenal surface) paced 180 
days in 3% hydrogen peroxide solution at 37 C: magnification, 
500 x (H,O,). 
weight (MW,) (Table 1). However, the MW, of B2 
(CAGE) samples was greater than, and that of 
Biomer (SUBQ) samples not significantly different 
from, the value for unimplanted controls. Neither 
Fig. 1. (a) SEM micrograph of Biomer prior to implant; magni- 
fication, 500 x (CONTROL). (b) SEM micrograph of Biomer 
sample implanted for 60 days subcutaneously in rats: magnili- 
cation, 500 x (SUBQ). (c) SEM micrograph of Biomer sample 
(strained to 400% and caged) implanted for IO weeks subcutane- 
ously in rats; magnification. 500 x (CAGE). 
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Biomer (CAGE), nor Pellethane (PACE) samples 
were analyzed by GPC. 
Discussion 
One in vitro (H202) and two in vivo (SUBQ 
and CAGE) models were used to study PEU 
degradation. However, experiments were con- 
ducted independently and therefore, implantation 
and incubation times, as well as the particular 
samples tested, differ in each experiment. 
Nonetheless, results compared favorably with in 
vivo pacemaker lead device performance (PACE). 
Experimental observations support the hypothe- 
sis that stress accelerates PEU degradation. Cracks 
in the Pellethane leads were observed only at sites 
of externally applied stress, both in vitro (H,O,; 
Fig. 2(b) and in vivo (PACE; Fig. 3(b)). Cracking 
in vivo was observed in stressed Biomer (Fig. l(c)) 
and B2 (data not shown) (CAGE), but not 
unstressed Biomer (Fig. l(b)) or B2 (data not 
shown) (SUBQ) samples. (Unstressed Biomer was 
not tested, and degradation of unstressed B2 
was not observed in the CAGE model, data not 
shown.) 
Metal ion catalyzed oxidation is generally 
accepted as the mechanism for pacemaker lead 
device failure [lo]. Surface cracks of Pellethane 
(H,Oz) samples were observed only at the stressed 
polymer-metal interface. However, degradation of 
the exterior surface of Pellethane (PACE) samples 
(Fig. 3(b)) was observed, due in part to the metal 
ion concentration in the subcutaneous 
environment. 
Changes in the molecular weight distribution of 
degraded PE U 
Fig. 3. (a) SEM micrograph of Pellethane pacemaker lead 
(exterior surface) prior to human implant. magnification, 500 x 
(CONTROL). (b) SEM mlcrograph of Pellethane pacemaker 
lead (extenor surface) retrieved after 3 years human implant; 
magnification, 500 x (PACE). 
While the MW, value of Pellethane samples 
decreased upon peroxide incubation in the H202 
model, that of Biomer did not significantly change 
in the SUBQ, and that of B2 increased in the 
CAGE models. Increased MW, of Biomer upon 
incubation with a silver nitrate solution [15], and 
after subcutaneous rat and canine implants [24] 
has been reported previously. Increased MW, was 
attributed to crosslinking of the polymer, and may 
also reflect the loss of low molecular weight frag- 
ments. While FT-IR spectra suggested degradation 
of high molecular weight chains in Biomer (SUBQ) 
samples, no change in MW, value was observed. 
This suggests degradation, in the absence of stress, 
at the surface but not the bulk of the polymer. 
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Fig. 4. (a) FT-IR spectrum of Biomer (SUBQ model); bottom, control. prior to implant; center, after 60 days subcutaneous rat Implant: 
top, spectral subtraction (implant -control). (b) FT-IR spectrum of Biomer (CAGE model); bottom, control, prior to implant; center, 
after 10 weeks subcutaneous rat cage Implant; top, spectral subtractlon (Implant-control). 




















Fig. 5. (a) FT-IR spectrum of Pellethane pacer lead, inter lumenal surface (H,O, model); bottom, prior to incubation; center, paced 
180 days in 3% hydrogen peroxide; top, spectral subtraction (implant -control). (b) FT-IR spectrum of Pellethane pacer lead, exterior 
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Number average molecular wetght (MW,) (Da) of PEU and PEUU samples degraded m vttro and m vtvo 
Polymer Model Incubation 
or implant 
time (days) 
MW, MW, AMW, 
(sample) (control) (7) 
Biomer (PEUU) SUBQ 60 97 440 98 400 -1 
Pellethane (PEU) HZ% 180 87000 103 000 -16 
B2 (PEUU) cage 70 89010 66 450 34 
Mechanism of PEW degradution 
Based upon the observation that PEU degrada- 
tion in vivo occurs primarily at the ether linkage, 
and that antioxidants inhibit this degradation [25], 
a hyperoxide radical attack on the x-carbon of the 
PEU soft segment was proposed as the first step 
in PEU degradation in the CAGE model [23]. 
Oxidation results in the formation of an ester 
linkage, which is susceptible to hydrolysis or ester- 
ase attack [26,27]. FT-IR/ATR analysis of PEUs 
tested using the H202, CAGE and SUBQ models. 
and of samples retrieved after human implant 
(PACE), support this mechanism. 
Spectra of the PEUs degraded in vivo (SUBQ, 
CAGE, and PACE; Figs. 4(a), 4(b), and 5(b), respec- 
tively) share common features. All show decreased 
peak intensity at 1110 cm - ‘, characteristic of PEU 
soft segment, and corresponding increased peak 
intensities at 1525 and 1590 cm _ ‘, characteristic 
of PEU hard segment. Increased peak intensities 
at 770 and 1174 cm- ‘, characteristic of polyester, 
were also observed. Decreased soft segment cou- 
pled with increased ester functionality at the surface 
suggests oxidative degradation. 
Pellethane pacer leads degraded in vitro (H,OJ 
display similar chemical changes. The spectrum of 
the inner lumen, which contacted the metal coil 
wire of the lead, also shows decreased peak inten- 
sity at 1110 cm - ’ and increased intensities at 770 
and 1174 cm - ’ (Fig. 5(a)). The spectrum of the 
outer polymer showed no such changes and resem- 
bled the control. These chemical changes are con- 
sistent with metal ion (from the wire coil) catalyzed 
oxidative degradation. 
Pretreatment of stressed PEU with plasma, or 
with plasma component x,-macroglobulin (cI~M), 
prior to incubation with peroxide and cobalt chlo- 
ride was reported to effect environmental stress 
cracking (ESC) [28]. ESC was hypothesized to 
result from synergistic interactions between qM, 
hyperoxide radicals, and applied material stress. 
Conclusions 
Applied external stress accelerates PEU 
degradation. 
Degradation in the in vitro H,O, model, the in 
vivo SUBQ and CAGE models, and the pacemaker 
lead device human implant (PACE) likely occurs by 
a common, metal ion catalyzed, oxidative degrada- 







J.W. Boretos and W.S. Pierce, Science, 158 (1976) 1481. 
J.W. Boretos. D.E. Detmer and J.H. Donachy, J. Boomed 
Mater. Res., 5 (1971 I 373. 
HE. Kambtc. SM. Murabayashi and Y. Nose. Chem. Eng. 
News, April 14, (1986) 31 
M. Szycher, J. Biomater. Appl , 3 (1988) 297. 
K.B. Stokes, J. Biomater. Appl., 3 (1988~ 228. 
K.B. Stokes and K Cobtan. Biomaterials. 3 (1982) 225. 
CL. Byrd, W. McArthur, K Stokes, M. Sivta. W.Z. Yahr 
and J. Green, Pace. 6 (1983) 868. 
L.M. van Gelder and M.I.H. El Carnal, Pace, 6 (I 983) 834 
M. Szycher, D. Dempsey and V.L. Poirier. Surface 
Fissuring of Polyurethane-based Pacemaker Leads, Second 
World Congress on Btomaterials, Tenth Annual Meetmg 
of the Soctety for Btomaterials, Washmgton, DC. 1984, p. 24 
K.B. Stokes. A. Court and P. Urbanskt. J. Biomater. Appl.. 
l(l987) 411. 
R.E. Phillips. M.C. Smith and R.J Thoma. J. Btomater. 
Appl., 3 (1988) 207 
SK. Phua, E. Casttllo. J.M Anderson and A. Hiltner, 
J. Biomed Mater. Rex. 26 (1992) 1019. 





B.D. Ratner, K.W. Gladhill and T.A. Horbett, J. Biomed. 
Mater Res., 22 (1988) 509. 
M. Bouvier, A S. Chawla and I. Hmberg, J Biomed. Mater. 
Res., 25 (1991) 773. 
A. Takahara, A.J. Court, R.W. Hergenrother and S.L. 
Cooper, J. Biomed. Mater. Res., 25 (1991) 341. 
G.F. MeiJs, S.J. McCarthy, E. Rizzardo, Y.-C. Chen, R.C. 
Chatelier. A. Brandwood and K. Schmdhelm, J. Biomed. 
Mater. Res.. 27 (1993) 345. 
B.J. Tyler and B.D. Ratner, J. Blamed. Mater. Res., 27 
(1993) 327. 
Q. Zhao, J. Anderson and A. Hiltner, J. Biomed. Mater. 
Res., 26 (1992) 1019. 
T. Krause, F. Robertson and R. Greco, J. Biomed. Mater. 
Res.. 27 (1993) 65. 
Q. Zhao, N. Topham, J.M. Anderson, A. Hiltner, G.A. 










and C. Payet, J. Appl. Polym. Sci., 46 (1992) 201. 
R. Hergenrother, H. Wabers and S.L. Cooper, J. Appl. 
Biomater., 3 (1992) 17. 
Y. Wu, Q. Zhao, J. Anderson, A. Hlltner, G. Lodoen and 
C. Payet, J. Blamed. Mater. Res.. 25 (1991) 725. 
C.S. Schollenberger and F.D. Steward, J. Elastoplast., 3 
(1971) 28 
M.D. Lelah and S.L. Cooper. Polyurethanes in Medicine, 
CRC Press, Boca Raton, FL, 1986, pp 205-206. 
Q.H Zhao, A.K. McNally, K.R. Rubin, M. Remer, Y. Wu, 
V. Rose-Caprara, J.M. Anderson, A. Hdtner, P. Urbanski 
and K. Stokes, J. Biomed. Mater. Res., 27 (1993) 379. 
F.J. Schoen, J.W. Tsao and R.J. Levy, Am. J. Pathol., 123 
(1986) 134. 
R. Marchant, A. Hlltner. C. Hamlin, A. Rabmovitch, 
R. Slobodkm and J.M. Anderson, J. Biomed Mater. Res., 
17 (1983) 301. 
